The bricks and mortar behind ViraCorp
We have an extensive global network of capabilities and resources
Our Research Facility
The university’s biomedical facilities and equipment are state-of-the-art, with a CL3 Laboratory and full access to the university’s resources as required for each project.
In the last REF, 91% of Lancaster’s research was rated as either internationally excellent or world leading. Lancaster University’s research is truly international in focus, with research partnerships in over 60 countries around the world.
Chief Scientific Officer
Prof. Muhammad Munir
Prof. Muhammad Munir is a molecular virologist at the Lancaster University with research experience on viral diagnostics, vaccine development and viral pathobiology. Prof. Munir has co-developed an artificial intelligence guided molecular diagnostic platform for SARS-CoV-2 detection which is CE Marked and MHRA approved. The system is being commercialized by Vidiia Ltd. He has developed a novel vaccine against CoVID-19 that blocks transmission and can be administered through the nose.